HK1069412A - Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria - Google Patents

Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria Download PDF

Info

Publication number
HK1069412A
HK1069412A HK05102781.4A HK05102781A HK1069412A HK 1069412 A HK1069412 A HK 1069412A HK 05102781 A HK05102781 A HK 05102781A HK 1069412 A HK1069412 A HK 1069412A
Authority
HK
Hong Kong
Prior art keywords
antibodies specific
chimeric antibodies
positive bacteria
gram positive
lipoteichoic acid
Prior art date
Application number
HK05102781.4A
Other languages
Chinese (zh)
Inventor
Jeffrey R. Stinson
Richard F. Schuman
James J. Mond
Andrew Lees
Gerald Walter Fischer
Original Assignee
Biosynexus Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosynexus Incorporated filed Critical Biosynexus Incorporated
Publication of HK1069412A publication Critical patent/HK1069412A/en

Links

HK05102781.4A 2001-12-21 2002-12-23 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria HK1069412A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/343,503 2001-12-21

Publications (1)

Publication Number Publication Date
HK1069412A true HK1069412A (en) 2005-05-20

Family

ID=

Similar Documents

Publication Publication Date Title
PL354112A1 (en) Application of anti-ctla-4 antibodies
AU2001294175A1 (en) Method of purifying antibody
IL212419A0 (en) Methods of administering anti-tnf antibodies
AU2002251913A1 (en) Hybrid antibodies and uses thereof
AU2002220843A1 (en) Humanised antibodies and uses thereof
WO2002030986A3 (en) HUMANIZED ANTI-LT-β-R ANTIBODIES
AU2002326531A1 (en) Monoclonal antibodies to activated erbb family members and methods of use thereof
AU2002256895A1 (en) Anti-TRAIL-R antibodies
IL158643A (en) Anti-hmg monoclonal antibodies and compositions containing the same
EP1463479A4 (en) Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
AU2001244109A1 (en) Closure of bacterial ghosts
AU2002354929A1 (en) Antibodies specific for nanotubes and related methods and compositions
AU2001256325A1 (en) Human and humanized fap-alpha-specific antibodies
AU2002340167A1 (en) Anti-hla-dr antibodies and the methods of using thereof
AU6949800A (en) Compositions and methods for the treatment of sepsis using antibodies to c5a
AU2003253621A1 (en) Modified "s" antibodies
AU5441000A (en) Human monoclonal antibody
EP1470237A4 (en) Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria
AU1097301A (en) Humanization of non-human, mammalian antibodies
AU2003210054A1 (en) Anti-rank monoclonal antibodies and pharmaceutical composition containing the same
AU2003276844A1 (en) Formulations of modified antibodies and methods of making the same
HK1069412A (en) Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
AU2002255897A1 (en) Ensemble-based strategy for the design of protein pharmaceuticals
AU2002365894A1 (en) Antibodies to magmas and uses thereof
AUPP385598A0 (en) Purification of antibodies